These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Evaluation of three live attenuated H2 pandemic influenza vaccine candidates in mice and ferrets. Chen GL; Lamirande EW; Cheng X; Torres-Velez F; Orandle M; Jin H; Kemble G; Subbarao K J Virol; 2014 Mar; 88(5):2867-76. PubMed ID: 24371061 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of A/H1N1/2009 split inactivated influenza A vaccine (GC1115) in mice and ferrets. Han HJ; Song MS; Park SJ; Byun HY; Robles NJC; Ha SH; Choi YK J Microbiol; 2019 Feb; 57(2):163-169. PubMed ID: 30706345 [TBL] [Abstract][Full Text] [Related]
34. Vaccine-associated enhanced respiratory disease is influenced by haemagglutinin and neuraminidase in whole inactivated influenza virus vaccines. Rajão DS; Chen H; Perez DR; Sandbulte MR; Gauger PC; Loving CL; Shanks GD; Vincent A J Gen Virol; 2016 Jul; 97(7):1489-1499. PubMed ID: 27031847 [TBL] [Abstract][Full Text] [Related]
35. Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections. Liu G; Song L; Reiserova L; Trivedi U; Li H; Liu X; Noah D; Hou F; Weaver B; Tussey L Vaccine; 2012 Nov; 30(48):6833-8. PubMed ID: 23000130 [TBL] [Abstract][Full Text] [Related]
36. Contribution of Neuraminidase to the Efficacy of Seasonal Split Influenza Vaccines in the Ferret Model. Rosu ME; Kok A; Bestebroer TM; de Meulder D; Verveer EP; Pronk MR; Dekker LJM; Luider TM; Richard M; van den Brand JMA; Fouchier RAM; Herfst S J Virol; 2022 Mar; 96(6):e0195921. PubMed ID: 35107371 [TBL] [Abstract][Full Text] [Related]
37. Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure. Wei CJ; Yassine HM; McTamney PM; Gall JG; Whittle JR; Boyington JC; Nabel GJ Sci Transl Med; 2012 Aug; 4(147):147ra114. PubMed ID: 22896678 [TBL] [Abstract][Full Text] [Related]
38. Composition of hemagglutinin and neuraminidase affects the antigen yield of influenza A(H1N1)pdm09 candidate vaccine viruses. Shirakura M; Kawaguchi A; Tashiro M; Nobusawa E Jpn J Infect Dis; 2013; 66(1):65-8. PubMed ID: 23429089 [TBL] [Abstract][Full Text] [Related]
39. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R mBio; 2017 Sep; 8(5):. PubMed ID: 28928215 [TBL] [Abstract][Full Text] [Related]
40. Immune efficacy of an adenoviral vector-based swine influenza vaccine against antigenically distinct H1N1 strains in mice. Wu Y; Yang D; Xu B; Liang W; Sui J; Chen Y; Yang H; Chen H; Wei P; Qiao C Antiviral Res; 2017 Nov; 147():29-36. PubMed ID: 28941982 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]